Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro[S]
Inhibition of acid sphingomyelinase (ASM), a lysosomal enzyme that catalyzes the hydrolysis of sphingomyelin into ceramide and phosphorylcholine, may serve as an investigational tool or a therapeutic intervention to control many diseases. Specific ASM inhibitors are currently not sufficiently charac...
Main Authors: | Eyad Naser, Stephanie Kadow, Fabian Schumacher, Zainelabdeen H. Mohamed, Christian Kappe, Gabriele Hessler, Barbara Pollmeier, Burkhard Kleuser, Christoph Arenz, Katrin Anne Becker, Erich Gulbins, Alexander Carpinteiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520436004 |
Similar Items
-
New Molecular Targets for Antidepressant Drugs
by: Johannes Kornhuber, et al.
Published: (2021-09-01) -
Sphingomyelinase D/Ceramide 1-Phosphate in Cell Survival and Inflammation
by: Io-Guané Rivera, et al.
Published: (2015-04-01) -
Blood sphingolipidomics in healthy humans: impact of sample collection methodology
by: Samar M. Hammad, et al.
Published: (2010-10-01) -
Effect of Expression of Human Glucosylceramidase 2 Isoforms on Lipid Profiles in COS-7 Cells
by: Peeranat Jatooratthawichot, et al.
Published: (2020-11-01) -
Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice
by: Liansheng Zhong, et al.
Published: (2018-01-01)